Narcissus bulb extract may benefit oily skinNarcissus bulb extract may benefit oily skin
IBR Ltd. conducted research at their laboratories on IBR-Dormin, to find its affect on oil, acne-prone skin.
February 4, 2014
IBR Ltd. conducted research on their product IBR-Dormin (narcissus tazetta bulb extract) and its benefits for oily, acne-prone skin. IBR-Dormin is a natural aqueous extract from narcissus bulbs in their dormant state that is able to slow cell proliferation. The research evaluated the safety and efficacy of IBR-Dormin in the reduction of oiliness in a randomized, double-blind, parallel treatment, placebo-controlled trial. The study took place over six weeks, with a two-week washout period.
Results were concluded from both instrumental assessments and self assessments. Sebum levels were measured by a sebumeter. There was a significant reduction in sebumeter readings with baseline from day three until week four with the IBR-Dormin and salicylic acid formulation. The commercial formulation showed significant reduction in sebumeter readings with baseline from day three until week two. The placebo showed a difference only at day three and at no other time.
The subjects reported a significant improvement in oiliness from all products except the placebo from day three and on. They also reported an improvement in shine with 1.5% IBR-Dormin formulation starting at week one. It was also reported that starting at week one, the 1.5% IBR-Dormin formulation and the commercial formula made their skin feel less dry. Subjects reports an overall improvement of skin appearance starting at week two when using the 1.5% IBR-Dormin formulation.
IBR concluded that the proliferation of sebocytes, the cells that produce sebum, is slowed with IBR-Dormin, with may assist in reducing skin oiliness, shine and improve overall appearance. Together with salicylic acid and other ingredients that fight acne, IBR-Dormin may decrease acne outbreaks.
IBR develops, manufacturers and sells natural active ingredients for the cosmetic, food and pharmaceutical industries. IBR performs its research at its own research laboratories.
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023